Vialwirebiotech, curated
July 3, 2026, 2:47 AM
June 6, 2026
- 2:32 PM · STAT News2:32 PMSTAT+: Lilly shares safety, tolerability data on its next-gen obesity drug — STAT News
- 9:00 AM · STAT News
- 12:00 AM · FT — Pharmaceuticals12:00 AMAstraZeneca chief warns group could withhold new drugs in Europe — FT — Pharmaceuticals
June 5, 2026
- 6:35 PM · TechCrunch
- 12:16 PM · BioPharma Dive12:16 PMStudy data convince Lundbeck to push new migraine drug forward — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMRoche develops PCR test to detect the Ebola Bundibugyo virus — BioWorld
- 12:00 PM · BioWorld12:00 PMHemab soars 89% on debut as biopharma IPOs stay strong in May — BioWorld
- 10:11 AM · PharmaVoice10:11 AMBMS under pressure in schizophrenia; Summit/Akeso on a winning streak — PharmaVoice
- 9:00 AM · BioWorld9:00 AMPfizer’s integrin β6 ADC advances intravesical therapy for NMIBC — BioWorld
- 9:00 AM · BioWorld9:00 AMSeed funding at Artan Bio supports work on aging — BioWorld
- 9:00 AM · BioWorld9:00 AMArvinas joins MJFF initiatives to advance LRRK2 research — BioWorld
- 6:00 AM · Drug Discovery World6:00 AMMarketing authorisation granted to measles therapy — Drug Discovery World
- 5:17 AM · Pharmaceutical Technology5:17 AMPfizer signs licence agreement with Chai for AI drug discovery — Pharmaceutical Technology
- 4:46 AM · Pharmaceutical Technology4:46 AMBiogen’s salanersen gains FDA breakthrough therapy designation for SMA — Pharmaceutical Technology
- 4:00 AM · Drug Discovery World4:00 AMTreatment for SLE significantly reduces disease activity — Drug Discovery World